{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:03:37Z","timestamp":1768889017899,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":416,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch MS Research Foundation","award":["#09-687 MS"],"award-info":[{"award-number":["#09-687 MS"]}]},{"name":"French Agence Nationale de la Recherche","award":["ANR-10-COHO-002"],"award-info":[{"award-number":["ANR-10-COHO-002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jns.2012.02.012","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T06:48:00Z","timestamp":1331362080000},"page":"117-122","source":"Crossref","is-referenced-by-count":32,"title":["Serum GFAP levels in optic neuropathies"],"prefix":"10.1016","volume":"317","author":[{"given":"Mithu","family":"Storoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Grabowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Confavreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon T.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2012.02.012_bb0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jns.2012.02.012_bb0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jns.2012.02.012_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1352458507084595","article-title":"NMO-IgG and Devic's neuromyelitis optica: a French experience","volume":"14","author":"Marignier","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2012.02.012_bb0020","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jns.2012.02.012_bb0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2012.02.012_bb0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","article-title":"Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum","volume":"20","author":"Kinoshita","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.jns.2012.02.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2009.07.014","article-title":"Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study","author":"Sabater","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.jns.2012.02.012_bb0040","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury","volume":"133","author":"Marignier","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.02.012_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.215.55","article-title":"A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica","volume":"215","author":"Takano","year":"2008","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"10.1016\/j.jns.2012.02.012_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2012.02.012_bb0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp.2009.196550","article-title":"Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases","volume":"82","author":"Petzold","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2012.02.012_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study","volume":"75","author":"Takano","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2012.02.012_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis","volume":"81","author":"Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2012.02.012_bb0070","doi-asserted-by":"crossref","first-page":"e23489","DOI":"10.1371\/journal.pone.0023489","article-title":"The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis","volume":"6","author":"Storoni","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2012.02.012_bb0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.02.012_bb0080","article-title":"Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?","author":"Downer","year":"2011","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jns.2012.02.012_bb0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2012.02.012_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2012.02.012_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2012.02.012_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.jns.2012.02.012_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jns.2012.02.012_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jim.2004.01.015","article-title":"An ELISA for glial fibrillary acidic protein","volume":"287","author":"Petzold","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jns.2012.02.012_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0361-9230(03)00091-1","article-title":"CSF and serum S100B: release and wash-out pattern","volume":"61","author":"Petzold","year":"2003","journal-title":"Brain Res Bull"},{"issue":"10","key":"10.1016\/j.jns.2012.02.012_bb0120","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archneurol.2010.269","article-title":"Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica","volume":"67","author":"Kalluri","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2012.02.012_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/1352458511412995","article-title":"Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients","author":"Ketelslegers","year":"2011","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.jns.2012.02.012_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.02.002","article-title":"Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome","volume":"17","author":"Petzold","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"10.1016\/j.jns.2012.02.012_bb0135","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3899\/jrheum.100148","article-title":"Utility of serum S100B protein for identification of central nervous system involvement in systemic lupus erythematosus","volume":"37","author":"Fragoso-Loyo","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jns.2012.02.012_bb0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-211-98811-4_46","article-title":"Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury","volume":"106","author":"Kleindienst","year":"2010","journal-title":"Acta Neurochir Suppl"},{"issue":"4","key":"10.1016\/j.jns.2012.02.012_bb0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0404.2010.01393.x","article-title":"Total tau and S100B proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone","volume":"123","author":"Bartosik-Psujek","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.jns.2012.02.012_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000258717","article-title":"Differential regulation of IgG-NMO autoantibodies on S100beta protein and disability in relapsing neuromyelitis optica","volume":"17","author":"Robinson-Agramonte","year":"2010","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.jns.2012.02.012_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2011.02.063","article-title":"Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome","volume":"494","author":"Fujii","year":"2011","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.02.012_bb0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis","volume":"298","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"issue":"Pt 1","key":"10.1016\/j.jns.2012.02.012_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1258\/000456303321016141","article-title":"Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases","volume":"40","author":"Verbeek","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jns.2012.02.012_bb0170","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/neu.2006.23.1185","article-title":"A critical analysis of the role of the neurotrophic protein S100B in acute brain injury","volume":"23","author":"Kleindienst","year":"2006","journal-title":"J Neurotrauma"},{"issue":"9","key":"10.1016\/j.jns.2012.02.012_bb0175","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.WNL.0000123092.97047.B1","article-title":"Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage","volume":"62","author":"Hasselblatt","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2012.02.012_bb0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1191\/1352458504ms1021sr","article-title":"Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis","volume":"10","author":"Petzold","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2012.02.012_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-5751-3-4","article-title":"Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a","volume":"3","author":"Lim","year":"2004","journal-title":"J Negat Results Biomed"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1200072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1200072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T05:57:15Z","timestamp":1543125435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1200072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0022510X1200072X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.02.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}